Three‐Month Tolerability of Orlistat in Adolescents with Obesity‐Related Comorbid Conditions
Obesity Research2002Vol. 10(7), pp. 642–650
Citations Over TimeTop 10% of 2002 papers
Jennifer R McDuffie, Karim A. Calis, Gabriel I. Uwaifo, Nancy G. Sebring, Erica M. Fallon, Van S. Hubbard, Jack A. Yanovski
Abstract
We conclude that, in adolescents, short-term treatment with orlistat, in the context of a behavioral program, is well-tolerated and has a side-effect profile similar to that observed in adults, but its true benefit versus conventional therapy remains to be determined in placebo-controlled trials.
Related Papers
- → Antiobese Effects of Diet Containing Medicinal Plant Water Extracts in High Fat Diet-Induced Obese Mice(2009)5 cited
- [Is orlistat medically essential for the treatment of obesity?].(1999)
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → Genentech taps Affimed’s antibodies(2018)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)